EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 272 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $2,000 | -100.0% | 45 | -100.0% | 0.00% | -100.0% |
Q3 2021 | $25,026,000 | -21.3% | 499,818 | -1.0% | 0.22% | -19.1% |
Q2 2021 | $31,787,000 | -31.6% | 504,637 | +0.8% | 0.28% | -35.3% |
Q1 2021 | $46,496,000 | -17.5% | 500,443 | -20.5% | 0.43% | -27.7% |
Q4 2020 | $56,375,000 | +17.9% | 629,181 | +35.9% | 0.59% | -5.4% |
Q3 2020 | $47,827,000 | +67.4% | 462,856 | +28.1% | 0.63% | +56.1% |
Q2 2020 | $28,570,000 | +13065.9% | 361,273 | +9523.7% | 0.40% | +9925.0% |
Q1 2020 | $217,000 | -36.4% | 3,754 | -40.6% | 0.00% | -20.0% |
Q4 2019 | $341,000 | -2.6% | 6,324 | -5.7% | 0.01% | 0.0% |
Q3 2019 | $350,000 | +8.4% | 6,704 | +0.1% | 0.01% | 0.0% |
Q2 2019 | $323,000 | -4.7% | 6,694 | -0.2% | 0.01% | 0.0% |
Q1 2019 | $339,000 | -14.6% | 6,709 | +0.1% | 0.01% | -37.5% |
Q4 2018 | $397,000 | -9.4% | 6,700 | +0.7% | 0.01% | +14.3% |
Q3 2018 | $438,000 | +33.1% | 6,652 | +2.0% | 0.01% | +40.0% |
Q2 2018 | $329,000 | +3.1% | 6,520 | +7.5% | 0.01% | 0.0% |
Q1 2018 | $319,000 | +59.5% | 6,065 | +40.7% | 0.01% | +66.7% |
Q4 2017 | $200,000 | -93.7% | 4,310 | -96.2% | 0.00% | -95.4% |
Q2 2016 | $3,158,000 | -13.1% | 112,307 | +12.3% | 0.06% | -19.8% |
Q1 2016 | $3,636,000 | +68.5% | 100,033 | +85.5% | 0.08% | +58.8% |
Q4 2015 | $2,158,000 | +39.4% | 53,925 | -0.8% | 0.05% | +37.8% |
Q3 2015 | $1,548,000 | -12.1% | 54,345 | +1.7% | 0.04% | -7.5% |
Q2 2015 | $1,762,000 | +11.2% | 53,460 | -3.0% | 0.04% | +11.1% |
Q1 2015 | $1,585,000 | +43.1% | 55,125 | +35.5% | 0.04% | +38.5% |
Q4 2014 | $1,108,000 | +48.1% | 40,695 | +15.9% | 0.03% | +30.0% |
Q3 2014 | $748,000 | +22.8% | 35,105 | +29.4% | 0.02% | +33.3% |
Q2 2014 | $609,000 | +47.5% | 27,125 | +65.9% | 0.02% | +36.4% |
Q1 2014 | $413,000 | +25.2% | 16,355 | +14.0% | 0.01% | +22.2% |
Q4 2013 | $330,000 | +43.5% | 14,350 | +18.8% | 0.01% | +28.6% |
Q3 2013 | $230,000 | +48.4% | 12,075 | +12.2% | 0.01% | +16.7% |
Q2 2013 | $155,000 | – | 10,760 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Laurus Investment Counsel Inc. | 119,994 | $12,399,000 | 6.09% |
Hillcrest Asset Management LLC | 161,826 | $16,721,000 | 2.96% |
SNYDER CAPITAL MANAGEMENT L P | 664,662 | $68,680,000 | 2.94% |
Copper Rock Capital Partners, LLC | 83,374 | $8,615,000 | 2.91% |
RICE HALL JAMES & ASSOCIATES, LLC | 623,132 | $64,388,000 | 2.60% |
Tygh Capital Management, Inc. | 130,526 | $13,487,000 | 2.56% |
PALISADE CAPITAL MANAGEMENT, LP | 428,875 | $44,316,000 | 1.31% |
BECK CAPITAL MANAGEMENT, LLC | 22,067 | $2,280,000 | 1.29% |
EARNEST PARTNERS LLC | 1,394,794 | $144,124,000 | 1.24% |
DC Investments Management, LLC | 10,945 | $1,131,000 | 1.24% |